Skip to main content
. Author manuscript; available in PMC: 2013 Sep 4.
Published in final edited form as: Am J Nephrol. 2012 Sep 4;36(3):252–260. doi: 10.1159/000342205

Table 1.

Demographic data for African American non-diabetic ESRD cases and African American non-nephropathy controls for set 1, set 2, and all samples combined. African ancestry is presented as a percentage calculated from 70 ancestry informative markers.

N Age (yr) Gender
(F)
BMI
(kg/m2)
Age at ESRD
(yr)
% African
ancestry

Set 1
non-nephropathy control 358 49.9 ± 10.1 45.3% 29.4 ± 6.7 78.0 ± 11.0
non-DM ESRD 296 53.4 ± 14.8* 42.6% 26.7 ± 7.3* 47.6 ± 15.7 79.9 ± 10.0*
Set 2
non-nephropathy control 279 46.5 ± 12.0 62.7% 31.2 ± 7.2 77.6 ± 10.4
non-DM ESRD 467 54.7 ± 14.4* 44.6%* 27.0 ± 6.7* 49.3 ± 15.5 80.1 ± 10.6*
Combined
non-nephropathy control 637 48.4 ± 11.1 52.7% 30.2 ± 7.0 77.8 ± 10.8
non-DM ESRD 763 54.2 ± 14.5* 44.0%* 26.6 ± 6.9* 48.7 ± 15.5 80.1 ± 10.4*
*

significant difference between cases and controls (p < 0.05)